ImageneBio Inc
IMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $950 | $987 | $1,155 | $5,414 |
| - Cash | $39 | $120 | $60 | $232 |
| + Debt | $8 | $11 | $6 | $7 |
| Enterprise Value | $918 | $877 | $1,101 | $5,188 |
| Revenue | $4 | $9 | $16 | $31 |
| % Growth | -61.8% | -41.3% | -49.6% | – |
| Gross Profit | $4 | $8 | -$49 | -$16 |
| % Margin | 100% | 88.9% | -311.8% | -52% |
| EBITDA | -$35 | -$74 | -$70 | -$34 |
| % Margin | -1,013.5% | -812.2% | -449.2% | -108.4% |
| Net Income | -$37 | -$68 | -$69 | -$34 |
| % Margin | -1,044.8% | -744.2% | -440.3% | -110.1% |
| EPS Diluted | -1.02 | -1.63 | -1.9 | -0.95 |
| % Growth | 37.4% | 14.2% | -100% | – |
| Operating Cash Flow | -$46 | -$80 | -$74 | -$60 |
| Capital Expenditures | $0 | -$0 | -$1 | -$2 |
| Free Cash Flow | -$46 | -$80 | -$76 | -$62 |